Open
SectorHealthcare
15.61 -1.2
24h
Min
14.88
Max
15.86
Income | 13M -72M |
---|---|
Sales | 18M 38M |
Profit margin | -189.28 |
Employees | 270 |
EBITDA | 20M -64M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +114.38% upside |
Next Earnings | 4 lis 2025 |
---|
Market Cap | 458M 1.4B |
---|---|
Previous open | 16.81 |
Previous close | 15.61 |
By Acuity
64%
36%
330 / 371 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 33.1 USD 114.38%
High 56 USD
Low 17 USD
Based on 12 Wall Street analysts offering 12 month price targets forSyndax Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$